Guizhou Yibai Pharmaceutical Co (SHSE:600594) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600594 Guizhou Yibai Pharmaceutical Co Ltd SHSE:600594
57 GF Score
Price ¥3.61
GF Value ¥2.91
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Guizhou Yibai Pharmaceutical Co Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

SHSE:600594
57GF Score
Guizhou Yibai Pharmaceutical Co Ltd SHSE:600594
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Guizhou Yibai Pharmaceutical Co (SHSE:600594) Overvalued in 2026?

Based on GuruFocus' analysis, Guizhou Yibai Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥3.61 is trading 24.1% above its estimated GF Value™ of ¥2.91. GuruFocus considers Guizhou Yibai Pharmaceutical Co to be Modestly Overvalued.

Key valuation signals for SHSE:600594:

  • Short Ratio:
  • GF Value™: ¥2.91 vs. price of ¥3.61 (24.1% above fair value)
  • GF Score™: 57/100 with 3 warning signs

No single metric tells the full story. See the SHSE:600594 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Guizhou Yibai Pharmaceutical Co Business Description

Address No. 220-1 Baiyun Avenue, Guiyang, Guizhou, CHN, 550008
Guizhou Yibai Pharmaceutical Co Ltd engages in the research, development, production, and sale of pharmaceutical products in China. Its products include tumor, cardio-cerebral vascular, respiratory system, anti-rheumatic, digestive system, pediatric, gynecological, andrological, anti-infection, anti-inflammatory, analgesic, tonic, and other drugs.
57GF Score

Get the complete analysis for SHSE:600594

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥3.61
Price
¥2.91
GF Value